Induced pluripotent stem cells offer promise for patient-specific regenerative therapy. But a study now cautions that, even when immunologically matched, these cells can be rejected after transplantation. See Letter p.212
References
Takahashi, K. & Yamanaka, S. Cell 126, 663–676 (2006).
Stadtfeld, M. & Hochedlinger, K. Genes Dev. 24, 2239–2263 (2010).
Wu, S. M. & Hochedlinger, K. Nature Cell Biol. 13, 497–505 (2011).
Zhao, T., Zhang, Z.-N., Rong, Z. & Xu, Y. Nature 474, 212–215 (2011).
Kim, K. et al. Nature 467, 285–290 (2010).
Polo, J. M. et al. Nature Biotechnol. 28, 848–855 (2010).
Hanna, J. et al. Science 318, 1920–1923 (2007).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
K.H. is an adviser to iPerian, Inc.
Rights and permissions
About this article
Cite this article
Apostolou, E., Hochedlinger, K. iPS cells under attack. Nature 474, 165–166 (2011). https://doi.org/10.1038/474165a
Published:
Issue Date:
DOI: https://doi.org/10.1038/474165a
- Springer Nature Limited
This article is cited by
-
Umbilical cord blood-derived non-hematopoietic stem cells retrieved and expanded on bone marrow-derived extracellular matrix display pluripotent characteristics
Stem Cell Research & Therapy (2016)
-
Induced pluripotent stem cells and their implication for regenerative medicine
Cell and Tissue Banking (2015)
-
Stem Cell Therapy: Challenges Ahead
The Indian Journal of Pediatrics (2015)
-
Tissue-Engineered Airway: A Regenerative Solution
Clinical Pharmacology & Therapeutics (2012)
-
Diagnosis in a dish: your skin can help your brain
Nature Medicine (2011)